신규 〔+〕-데쿠르신-구조이성체 합성 유도체〔decursin-structural isomer synthesis derivative〕를 유효성분으로 포함하는 아토피성 피부염 질환의 치료 및 예방용 조성물

    公开(公告)号:KR1020100116984A

    公开(公告)日:2010-11-02

    申请号:KR1020090035688

    申请日:2009-04-23

    Abstract: PURPOSE: A (+)-decursin-structural isomer synthetic derivative compound of novel structure is provided to suppress MCP-1, IL-16 and IL-18 secretion and to treat atopic dermatitis. CONSTITUTION: A (+)-decursin-structural isomer synthetic derivative compound of novel structure is denoted by general formula I or II. A pharmaceutical composition for preventing and treating atopic dermatitis contains (+)-decursin-structural isomer or pharmaceutically acceptable salt as an active ingredient. A health food for preventing and treating atopic dermatitis contains the (+)-decursin-structural isomer synthetic derivative compound or pharmaceutically acceptable salt as an active ingredient. The health food is used in the form of powder, granule, tablet, capsule or beverage.

    Abstract translation: 目的:提供新型结构的(+) - 前体结构异构体合成衍生物,以抑制MCP-1,IL-16和IL-18的分泌并治疗特应性皮炎。 构成:新型结构的(+) - 前衍生物 - 结构异构体合成衍生化合物由通式I或II表示。 用于预防和治疗特应性皮炎的药物组合物含有(+) - 前胡素结构异构体或药学上可接受的盐作为活性成分。 用于预防和治疗特应性皮炎的保健食品含有(+) - 前胶结构异构体合成衍生化合物或药学上可接受的盐作为活性成分。 保健食品以粉末,颗粒,片剂,胶囊或饮料的形式使用。

Patent Agency Ranking